Similar articles

• Embryopathy in infant conceived one year after termination of maternal etretinate: a reappraisal.

  [No authors listed] [No authors listed] Lancet. 1988 Nov 26;2(8622):1254. Lancet. 1988. PMID: 2903985 No abstract available.
• Embryopathy in infant conceived one year after termination of maternal etretinate.

  Lammer EJ. Lammer EJ. Lancet. 1988 Nov 5;2(8619):1080-1. doi: 10.1016/s0140-6736(88)90101-8. Lancet. 1988. PMID: 2903308 No abstract available.
• [Embryonal malformation following etretinate therapy of Darier's disease in the mother].

  Kietzmann H, Schwarze I, Grote W, Ravens U, Jänig U, Harms D. Kietzmann H, et al. Dtsch Med Wochenschr. 1986 Jan 10;111(2):60-2. doi: 10.1055/s-2008-1068402. Dtsch Med Wochenschr. 1986. PMID: 3940838 German.
• Teratogenic risk with etretinate and acitretin treatment.

  Geiger JM, Baudin M, Saurat JH. Geiger JM, et al. Dermatology. 1994;189(2):109-16. doi: 10.1159/000246811. Dermatology. 1994. PMID: 8075435 Review.
• ABC of clinical genetics. Dysmorphology and teratogenesis.

  Kingston HM. Kingston HM. BMJ. 1989 May 6;298(6682):1235-9. doi: 10.1136/bmj.298.6682.1235. BMJ. 1989. PMID: 2502226 Free PMC article. Review. No abstract available.